Andrew D. Kelly - Concepedia

Author

Andrew D. Kelly

Temple University ORCID

Also Known As

A D Kelly, Andrew D Kelly, Andrew D. Kelly, Andrew David Kelly, Andrew Kelly, Kelly, Andrew, Kelly., Andrew David

Publications

948

Citations

H-Index

Concepts

All Affiliations

Temple University Harvard University Beth Israel Deaconess Medical Center Dana-Farber Cancer Institute Massachusetts General Hospital

About

Andrew D. Kelly is an author at Temple University specializing in engineering, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	4	4	89
2	Medicine	4	4	155
3	Health Sciences	2	2	24
4	Cell Biology	2	2	103
5	Biochemistry	1	1	77

Andrew D. Kelly

Publications

651

Citations

H-Index

Page 1

	Year	Citations
TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer Charly R. Good, Shoghag Panjarian, Andrew D. Kelly, Cancer Research	2018	172
MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32 Andrew D. Kelly, Benjamin Haibe‐Kains, Katherine A. Janeway, Genome Medicine	2013	116
Metabolomic Profiling from Formalin-Fixed, Paraffin-Embedded Tumor Tissue Using Targeted LC/MS/MS: Application in Sarcoma Andrew D. Kelly, Susanne B. Breitkopf, Min Yuan, PLoS ONE Metabolomic ProfilingTumor BiologyBioanalysisBiomarker DiscoveryCancer Metabolism	2011	77
An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets Katherine E. Hill, Andrew D. Kelly, Marieke L. Kuijjer, Journal of Hematology & Oncology	2017	42
MicroRNA-155 expression is independently predictive of outcome in chordoma Eiji Osaka, Andrew D. Kelly, Dimitrios Spentzos, Oncotarget	2015	40
A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome Andrew D. Kelly, Heike Kroeger, Jumpei Yamazaki, Leukemia Hematological MalignancyEngineeringMedicineGeneticsAcute Myeloid Leukemia	2017	39
Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in human osteosarcoma Christopher B. Lietz, Erik T. Newman, Andrew D. Kelly, Communications Biology	2022	34
Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia Woonbok Chung, Andrew D. Kelly, Patricia Kropf, Clinical Epigenetics	2019	28
Next-generation sequencing and microarray-based interrogation of microRNAs from formalin-fixed, paraffin-embedded tissue: Preliminary assessment of cross-platform concordance Andrew D. Kelly, Katherine E. Hill, Mick Correll, Genomics BioinformaticsFunctional GenomicsCross-platform ConcordanceEngineeringMedicine	2013	26
Pan-cancer landscape of <i>CD274</i> (PD-L1) rearrangements in 283,050 patient samples, its correlation with PD-L1 protein expression, and immunotherapy response Andrew D. Kelly, Karthikeyan Murugesan, Zheng Kuang, Journal for ImmunoTherapy of Cancer	2021	16

Page 1